BioScience Health Innovations (BHIC) Return on Sales (2023 - 2025)
Historic Return on Sales for BioScience Health Innovations (BHIC) over the last 3 years, with Q3 2025 value amounting to 0.01%.
- BioScience Health Innovations' Return on Sales fell 1100.0% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.19%, marking a year-over-year increase of 1600.0%. This contributed to the annual value of 0.05% for FY2024, which is 4700.0% up from last year.
- Latest data reveals that BioScience Health Innovations reported Return on Sales of 0.01% as of Q3 2025, which was down 1100.0% from 0.26% recorded in Q2 2025.
- BioScience Health Innovations' Return on Sales' 5-year high stood at 0.35% during Q1 2025, with a 5-year trough of 2.19% in Q1 2023.
- Moreover, its 3-year median value for Return on Sales was 0.01% (2025), whereas its average is 0.28%.
- In the last 5 years, BioScience Health Innovations' Return on Sales soared by 19900bps in 2024 and then tumbled by -1100bps in 2025.
- BioScience Health Innovations' Return on Sales (Quarter) stood at 0.13% in 2023, then skyrocketed by 113bps to 0.02% in 2024, then crashed by -148bps to 0.01% in 2025.
- Its Return on Sales stands at 0.01% for Q3 2025, versus 0.26% for Q2 2025 and 0.35% for Q1 2025.